BARRY BAKER: Open Payments
NPI 1497716690 · RISING SUN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 15 payments from 9 companies in 2025. Trend: 2023 $110 · 2024 $388 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $206 |
| PFIZER INC. | 3 | $59 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Exact Sciences Corporation | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: AIRSUPRA, BREZTRI, PREVNAR 20, ROTATEQ, The Cologuard Plus Collection Kit, ELIQUIS, JOURNAVX, KISUNLA.
Industry payments across MD — which companies pay providers there.
